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Abstract
Aim To investigate potential factors on MR imaging that
could be used to predict migration of uterine fibroids post-
UAE.
Methods and Materials We retrospectively reviewed
patients referred for UAE having pre-procedural and 6
months post-procedural MRI, at a tertiary centre, over a
1-year period. Pre- and post-UAE images were reviewed in
64 women by two radiologists to identify the sub-type,
dimensions, and infarction rate of each dominant fibroid.
The shortest distance between the fibroid and the
endometrial wall was measured to determine intramural
fibroid movement. Paired sample T tests and two-sample
T tests were used to compare between pre- and post-em-
bolization variations and between migrated and non-mi-
grated intramural fibroids, respectively. After preliminary
results suggested potential predictors of intramural fibroids
migration, we tested our findings against the non-dominant
intramural fibroids in the same patients.
Results Review of images revealed 35 dominant intramu-
ral fibroids, of which eight migrated to become submucosal
fibroids, while five were either partially or completely
expelled. These 13 migrated fibroids had a shorter pre-
procedural minimum endometrial distance (range
1–2.4 mm) and greater maximum fibroid diameter (range
5.1–18.1 cm), when compared to non-migrating fibroids.
On image reassessment, the migrated non-dominant intra-
mural fibroids had a minimum endometrial distance and
maximum fibroid diameter within the same range.
Conclusion Intramural fibroids with a minimum endome-
trial distance less than 2.4 mm and a maximum fibroid
diameter greater than 5.1 cm have a high likelihood of
migrating towards the endometrial cavity after UAE.
Keywords Fibroids  Uterine fibroid embolisation 
Uterine artery embolisation  Gynaecologic
interventions  Fibroid MRI
Introduction
Uterine artery embolization (UAE) is now established as a
highly effective treatment for symptomatic fibroids [1–6],
the commonest benign tumour in women of reproductive
age [7, 8]. The available evidence on UAE confirms that
the procedure is efficacious for symptom relief in a sub-
stantial proportion of patients [9], thus is now considered as
an alternative to hysterectomy and myomectomy. Imaging
protocols for UAE are well developed: there is a pre-pro-
cedural assessment by magnetic resonance imaging (MRI)
followed by a post-procedural MRI 3–6 months later [10].
Various studies [10–14] have revealed that pre-procedural
MRI improves patient selection and reduces treatment
failure or complications, while post-procedural MRI allows
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for the assessment of treatment response or failure, in
conjunction with symptomatic improvement.
Over a decade of performing UAE, we have observed
that while the majority of fibroids will have undergone
infarction on the MRI post-embolization, there are instan-
ces of fibroids showing a change in their location towards
the uterine cavity, a phenomenon we have termed ‘‘fibroid
migration’’. Verma et al. [15, 16] have reported that in
1–5% of cases, fibroids do change locations: submucosal
fibroids can become intracavitary and subserosal fibroids
can develop an intramural or submucosal component—as
in our own observations, the change in location appears to
be predominantly towards the uterine cavity. This obser-
vation warrants careful study and understanding because it
has potential clinical implications. It is likely to be the
underlying mechanism behind the complication of fibroid
extrusion and chronic vaginal discharge some women
experience post-UAE. Perhaps even more importantly,
fibroids changing location could impact negatively on
reproduction. A fibroid migrating from an intramural
position to an intracavitary position could represent one of
the mechanisms of endometrial damage observed post-
UAE [17], and intramural fibroids becoming submucosal
could interfere with implantation. Thus an understanding of
the factors associated with changes in fibroid location
following UAE could enhance the quality of patient
counselling and management. Those women wishing to
conceive but where migration is likely could be advised
surgical intervention, if it is proven that surgery has fer-
tility benefits in such cases. Even if symptom relief is the
predominant end-point for the planned treatment, they
should be warned of the increased risk of fibroid expulsion
per vagina [18].
Although studies have noted this change in location in
intramural fibroids following UAE [18], our review of the
literature failed to find published data evaluating charac-
teristics that could predict these alterations. In this retro-
spective study, our aim is to assess imaging findings on
pre-procedural MRI imaging in order to identify parame-
ters that can be used to predict post-UAE migration of
intramural fibroids.
Materials and Methods
Patients
This was a retrospective study of 73 consecutive patients
with symptomatic fibroids referred for UAE at St George’s
University Hospital NHS Foundation Trust between 1st
June 2014 and 30th May 2015. The patients were identified
through the Patient Archiving and Communication System
(PACS) and had a mean age 45 years (range 30–60 years).
Patients were required to have undergone a pre-procedural
MRI followed by UAE and then a post-procedural MRI
6 months after embolization. Consequently, nine patients
were excluded from the study because either the pre- or
post-procedural MRI was not available for viewing, leav-
ing a total study group of 64 women.
MRI Technique
Pelvic MRI was performed with a GE Signa Excite (GE
Medical Systems, USA) 1.5 T MRI scanner. Pre- and post-
procedural MRIs were performed according to identical
protocols.
Sequences acquired were as follows: sagittal T2 fast
spin echo (FSE); axial T1 FSE; axial T2 FSE; and axial T1
fat-saturated postcontrast. Slice thickness of 5–6 mm was
used with variable fields of view.
Contrast-enhanced sequences were acquired after intra-
venous injection of 20 mL gadolinium–DOTA (gadoteric
acid; Dotarem, Guerbet, Obex). MRA was performed
selecting the region of interest at the abdominal aorta and
triggering image acquisition at approximately 25 s. Maxi-
mum-intensity projections of the abdomen and pelvis to the
level of the renal arteries were reconstructed.
Embolization Technique
The embolization procedure was performed by certified
interventional radiologists in our institution via a bilateral
transfemoral approach under local anaesthesia with selec-
tive catheterization of uterine arteries with 4F RIM
catheters (Rösch Inferior Mesenteric Torcon Beacon Tip
catheter, Cook Medical, USA). Two types of embolic
agents were used: non-spherical PVA (nsPVA) (n = 16)
350–500 lm (Contour PVA, Boston Scientific, USA) and
microspheres (n = 48) 700–900 lm (Embosphere, Bio-
sphere Medical, Roissy, France). In both groups, if greater
than four vials were required, the size of particles used was
increased.
Embolization was performed in a standardized fashion:
the RIM catheters were advanced to the contralateral
internal iliac and uterine artery, sequentially over the aortic
bifurcation and into the transverse segments of the uterine
arteries, or as far as required to ensure a stable position.
Microcatheters (Progreat 2.7F microcatheter, Terumo
Medical Corporation, Europe) were used if the uterine
arteries were small or the anatomy was unfavourable. Two
operators carry out a bilateral hand-injected angiogram to
confirm adequate position after which bilateral simultane-
ous injection of nsPVA or Microspheres was performed to
achieve embolization with angiographic stasis of contrast
within the transverse segments of the uterine arteries for
approximately 10 cardiac beats. It was routine to cease
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embolization for 5 min, then subsequently reinject contrast
bilaterally to confirm stasis of contrast in the transverse
segments. If ovarian arterial collaterals were identified,
catheter flush aortograms were performed after bilateral
uterine artery embolization. Selective ovarian embolization
was performed if the patient had consented prior to the
treatment.
Image Review
All MRI images were independently reviewed by two
experienced radiologists with subsequent consensus
review. On both pre-procedural and post-procedural ima-
ges, the three-dimensional maximal measurements of the
uterus and dominant fibroids were obtained using axial and
sagittal T2-weighted MR images. In patients with multiple
fibroids, the dominant fibroid was defined as the fibroid
with the largest single dimension. Assuming an ellipsoid
shape for both the uterus and the dominant fibroid, the
volume was calculated in cubic centimetres using a prolate
ellipsoid volume formula (0.523 9 length 9 width 9
depth). The relative difference in volume was calculated
and expressed as a percentage. In all post-procedural
images, the percentage of fibroid infarction (non-enhancing
fibroid tissue following contrast injection) was noted and
categorized as 100%, 90–99%, 50–89%, or\ 50%.
All dominant fibroids were categorized as being sub-
mucosal, intramural, subserosal, or endocavitary. A fibroid
was defined as: submucosal, if any portion of the fibroid
contacted the endometrium; intramural, if the fibroid was
completely surrounded by myometrium; subserosal, if the
fibroid partially or completely lacked a surrounding myo-
metrium and abutted, or deformed, the serosal layer; and
endocavitary, if greater than 50% of the surface area of the
fibroid was surrounded by endometrium.
Additional measurements were obtained pre- and post-
procedurally in the same plane on MRI for the dominant
intramural fibroids by recording the shortest distance
between the fibroid and the endometrial wall and between
the fibroid and the serosal wall.
After obtaining preliminary results suggesting potential
parameters to predict migration of intramural fibroids, we
tested our findings against the non-dominant intramural
fibroids in all our cases. We reviewed all images again and
measured the non-dominant intramural fibroids as detailed
above. We then determined if these fibroids had migrated
and assessed for characteristic predictors.
Statistical Analyses
Paired sample T tests were performed to assess pre- and
post-embolization variations in the dominant intramural
fibroid’s volume and maximal diameter. A two-sample
T test was used to analyse parameters between migrated
and non-migrated dominant intramural fibroids. Statistical
significance was set to a p value of 0.05. Statistical power
was not tested.
Results
Image Review Observations
Of the 64 dominant fibroids on pre-procedural MRI, 35
(55%) were intramural, 8 (13%) were submucosal, 20
(31%) were subserosal, and 1 (0.01%) was intracavitary.
The mean maximal fibroid diameter of all dominant
fibroids was reduced by 22.4% (range 0–100%; SD = 24.9;
two-tailed p\ 0.005; t = 5.4). The overall mean reduction
in uterine volume was 40.1% (range 1.1–94.9%; SD =
20.8; two-tailed p\ 0.005; t = 7.5) and the mean reduc-
tion in fibroid volume was 40% (range 0.4–100%; SD =
29.3; two-tailed p\ 0.005; t = 3.4). Table 1 details the
above parameters within each classification. Twenty-two
(34%) patients had adenomyosis confirmed on pre-proce-
dural MRI, but on post-procedural MRI, 15 (23%) patients
were identified with adenomyosis. Complete infarction of
dominant fibroids was seen in 40 (63%) of dominant
fibroids, while seven (11%) were classed as 90–99%
infarction, six (9%) as 50–89% and 11 (17%) as less than
50% (Table 2).
Fibroid migration was noted in 13 of the 35 dominant
intramural fibroids (37%) with end-points as follows: eight
became submucosal, two were partially expelled, and three
were potentially completely expelled. The last three
fibroids were assumed expelled as they were no longer
visible at post-procedural MRI, and on review of clinical
notes, vaginal discharge was described by the respective
patients. Table 3 shows that in the 13 migrated dominant
intramural fibroids, the mean pre-procedural minimal dis-
tance from fibroid to the endometrium was less than that
seen with the non-migrating dominant intramural fibroids
(two-tailed p = 0.01, t = 2.7). Furthermore, the mean pre-
procedural maximum fibroid diameter of migrated domi-
nant intramural fibroids was greater, with statistical sig-
nificance, than those that did not migrate (two-tailed
p = 0.02, t = 2.6). Although the mean fibroid volume of
the migrated dominant intramural fibroids was also greater
than the non-migrating fibroids, statistical significance was
not reached (two-tailed p = 0.14, t = 1.6). All but one
migrated dominant intramural fibroids were completely
infarcted; the one exception being 90–99% infarcted.
With respect to the eight dominant submucosal fibroids,
we noted that one had migrated to become intracavitary
and another to be partially expelled. The mean pre-proce-
dural maximal fibroid diameter was greater in migrating
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dominant submucosal fibroids (mean = 7.2, range =
6.6–7.8) compared to non-migrating ones (mean = 5.5,
range = 3.4–8.1), but this difference was not statistically
significant. Both migrating dominant submucosal fibroids
were completely infarcted on post-procedural MRI and the
patient with the partially expelled fibroid had adenomyosis.
Between the pre- and post-procedural MRI, one dominant
subserosal fibroid was not evident on post-procedural MRI
and assumed expelled. The one dominant intracavitary
fibroid had poor infarction and did not appear to migrate.
Upon image reassessment of the non-dominant intra-
mural fibroids, only four were found to have migrated. The
mean minimal endometrial distance in these four cases was
2.05 mm (range 1.6–2.3), and the mean maximal fibroid
diameter was 6.28 cm (range 5.1–6.8). All cases had
complete infarction. Two of the fibroids migrated into a
submucosal category, one was partially expelled, and one
was completely expelled.
In summary, intramural fibroids with a minimum
endometrial distance less than 2.4 mm and a maximum
fibroid diameter greater than 5.1 cm have a high likelihood
of migrating towards the endometrial cavity after UAE.
Discussion
Patients undergoing UAE have comparable quality of life
outcomes to hysterectomy and myomectomy with rela-
tively minor complications [1–6, 19, 20]. Of the recognized
complications, the passage of leiomyoma tissue, accom-
panied by symptoms of pain, bleeding or infection, as well
as fibroid impaction are likely to be a direct result of
fibroids migrating into the uterine cavity [21]. Fibroid
migration could also be a mechanism for the endometrial
injury reported by Mara et al. [17] as a consequence of
UAE; this in turn may compromise fertility potential.
Therefore an understanding of the underlying processes,
mechanisms, and sequelae is important for the appropriate
counselling of patients and their management.
Table 1 Mean difference in maximal dimensions, uterine volume, and fibroid volume of dominant fibroids within classifications expressed as
percentages
Dominant fibroid
classification
No. (%) Mean maximal fibroid diameter
difference (%)
Mean uterine volume
difference (%)
Mean fibroid volume
difference (%)
Intramural 35 (55%) 23.4 (0–100) 41.8 (1.7–94.9) 39.6 (0.4–100)
Submucosal 8 (13%) 22.0 (1.3–47.1) 46.5 (24–89) 37.7 (3–83.1)
Subserosal 20 (31%) 21.3 (0–100) 35.1 (1.1–87.3) 42 (3.2–100)
Endocavitary 1 (1%) 14.3 27.1 35.7
Table 2 Infarction rates of dominant fibroids
Dominant fibroid classification No. (%) 100% Infarction 90–99% Infarction 50–89% Infarction \ 50% infarction
Intramural 35 (55%) 26 (74.3%) 3 (8.6%) 2 (5.7%) 4 (11.4%)
Submucosal 8 (13%) 5 (62.5%) 1 (12.5%) 1 (12.5%) 1 (12.5%)
Subserosal 20 (31%) 9 (45%) 3 (15%) 3 (15%) 5 (25%)
Endocavitary 1 (1%) 0 0 0 1 (100%)
Table 3 Comparison of pre-procedural dominant intramural fibroid measurements between migrating and non-migrating
Pre-procedural dominant intramural fibroid
variables
Migrating dominant intramural fibroids
(n = 13)
Non-migrating dominant intramural fibroids
(n = 22)
Mean minimal endometrial distance (mm) 1.7 (1.0–2.4)* 10.2 (0.5–73)*
Mean maximal fibroid diameter (cm) 10.3 (5.1–18.1)* 7.2 (3.0–15.9)*
Mean fibroid volume (mL) 476.8 (57.6–2043.3) 189.7 (11.4–837.4)
Number with adenomyosis 5 6
*Statistical significance (two-tailed p\ 0.05)
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Our results have demonstrated that 37% (n = 13) of
dominant intramural fibroids underwent migration to
become submucosal or were expelled. Our measurements
showed that only these 13 migrated dominant intramural
fibroids had a pre-procedural minimum distance from the
endometrium of 1–2.4 mm, and of these, all had a pre-
procedural maximum fibroid diameter greater than 5.1 cm
(Fig. 1). Since this finding suggested that an intramural
fibroid with a pre-procedural minimum endometrial dis-
tance of less than 2.4 mm and a maximum fibroid diameter
greater than 5.1 cm will migrate to either become submu-
cosal or be expelled, we decided to test this hypothesis on
the non-dominant intramural fibroids in our unselected
patient population. Coincidentally, all the non-dominant
intramural fibroids that underwent migration also fell under
these parameters. It has previously been postulated that
fibroids with a portion of its circumference contacting the
endometrium can be expelled [22]; however, our study
shows that those within 1–2.4 mm distance to the endo-
metrium also predisposes an intramural fibroid to migrate
towards the uterine cavity. We do not know of the
anatomical or physiological explanation for the fibroids
migrating towards, rather than away from the uterine
cavity. It may be that the reduction in the uterine volume
pushes the large fibroid towards the endometrial wall;
another possibility is that the ischaemic change caused by
the embolization damages the adjacent endometrium
resulting in expulsion of the fibroid through the damaged
layer. However these explanations are hypothetical and not
proven.
How do our findings compare to previous reports?
While we found that 37% of dominant intramural fibroids
underwent migration to become submucosal or expelled,
Verma et al. [16] reported a much smaller percentage (4%)
of dominant intramural fibroids changing to a submucosal
location after UAE. It is not immediately apparent as to
why there should be such a large difference between the
two studies, but there were differences in study design. Our
study sample included only the dominant fibroid in each
patient, whereas Verma et al. [16] had evaluated between
one and five fibroids per patient. The submucosal fibroid
parameters of pre-procedural interface–dimension ratio of
0.55–0.83 and a maximum fibroid dimension of 3–17 cm
were observed by Verma et al. [16] to be more likely to
become intracavitary after UAE. We had one fibroid that
met these measurements; however, it was not found to have
migrated to an intracavitary position. Instead, the fibroid in
our study that migrated to become intracavitary after UAE
had a maximal fibroid diameter of 6.6 cm and an interface–
dimension ratio of 0.94. More samples and further studies
can likely assess the reproducibility of the parameters
suggested by Verma et al. [16].
We acknowledge the limitations in our study consequent
upon the small sample size of 64 patients. However, our
data can be considered as preliminary results revealing a
correlation between dominant intramural fibroid migration,
pre-procedural distance to endometrium, and pre-proce-
dural maximum fibroid diameter. While measuring the
minimum distance to endometrium may be difficult to
identify in some cases, we believe that in most cases, it can
be easily assessed with routine measurements of dominant
uterine fibroids. In our study, post-procedural MR images
were obtained after 6 months. Future studies may assess
whether a scan more than 6 months after UAE may reveal
the extent of migration in the dominant intramural fibroids
that became submucosal.
Fig. 1 A Sagittal T2-weighted
MR image shows an intramural
fibroid measuring 81.3 mm in
long axis with 2 mm shortest
distance to the endometrium.
B Repeat MRI 6 months
following uterine artery
embolization demonstrates a
17.7 mm discontinuity in the
endometrial lining. This was
interpreted as an expelled
fibroid given the imaging and
clinical correlation of tissue-like
discharge described by the
patient
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Conclusion
In this pilot study of dominant fibroid migration, we found
that dominant intramural fibroids have a high likelihood of
migrating towards the endometrial cavity if the pre-pro-
cedural MRI minimum distance to the endometrium is less
than 2.4 mm and the maximum fibroid diameter is greater
than 5.1 cm. Additional research in this area is required,
not least to test the reproducibility of our findings, and
further define other parameters that could enhance the
predictive potential of pre-UAE MRI fibroid
characteristics.
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